RxDoctor Payments Data

Spencer Hamner, PA

Surgical · Lincoln, NENPI 1598853715

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,034 of the $4,030 with a category attached, or 75.3%. It is spread thinly across 17 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,030in general payments, 2019–2025

Across 177 payments — averaging $22.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$780
  • Sun Pharmaceutical Industries Inc.$724
  • Incyte Corporation$694
  • Johnson & Johnson$615
  • Lilly USA, LLC$253
  • UCB, Inc.$228
  • plus $736 from 11 others

What the payments were for

  • Food & beverage$3,03475%
  • Education$99525%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,030 in reported general payments places this provider in the 90th percentile of 101 surgical providers in Nebraska.

See all surgical providers in Nebraska

Medicare billing

Part B allowed, 2024
$412,736
Medicare patients
1,101
Services billed
5,905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab25$92,793
Clobetasol Propionate163$7,925
Fluorouracil60$4,517
Metronidazole47$3,161
Mupirocin394$2,999
Ketoconazole147$2,851
Tacrolimus12$1,484
Triamcinolone Acetonide145$1,045
Doxycycline Monohydrate46$1,003
Doxycycline Hyclate55$789
Betamethasone Dipropionate12$600
Clindamycin Phosphate27$585
Desonide22$542
Betamethasone Valerate12$383
ValacyclovirValacyclovir Hcl27$332

Paid to pharmacies, not to this prescriber.

Other surgical in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →